Dr. Gaurav Gupta, MD
Claim this profileVirginia Commonwealth University
Studies Kidney Complication
Studies Cytomegalovirus
6 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Gaurav Gupta, MD is currently running
Letermovir
for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
This study is being done to compare the effectiveness of de novo Letermovir versus valganciclovir in preventing the development of cytomegalovirus viremia or symptomatic disease in African American kidney transplant recipients within the first year after transplantation. There are two arms in the study: Arm 1: Prophylaxis: This group includes freshly transplanted high risk (CMV D+/R-) African American Kidney recipients who will be on prophylactic Letermovir for 6 month. Arm 2: Prophylaxis: This group includes high-risk African American kidney transplant recipients who had already completed the 6 month prophylactic course with the standard of care Valganciclovir.
Recruiting2 awards Phase 3
HCV Prophylaxis Strategies
for Kidney Transplant Recipients
This study is being done to find out the best time to start medication for Hepatitis C Virus (HCV) in HCV-negative recipients of HCV-positive (HCV D+/R-) kidney transplants. Participants will be randomized into one of two groups: Arm 1 - Prophylaxis: This group will start the HCV medication before transplant and will take a shorter course of HCV medication for 2 weeks. Arm 2 - Transmit and Treat: This group will start the HCV medication after transplant and will take the full course (12 weeks) of HCV medication.
Recruiting1 award N/A
More about Gaurav Gupta, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Gaurav Gupta, MD has experience with
- Letermovir
- Prophylaxis (P2W)
- Transmit And Treat (T&T)
- Integrated Diagnostic System
- HLA Antibody
- MMDx
Breakdown of trials Gaurav Gupta, MD has run
Kidney Complication
Molecular Diagnostic System Study
Molecular Diagnostics Reporting System
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gaurav Gupta, MD specialize in?
Gaurav Gupta, MD focuses on Kidney Complication and Cytomegalovirus. In particular, much of their work with Kidney Complication has involved treating patients, or patients who are undergoing treatment.
Is Gaurav Gupta, MD currently recruiting for clinical trials?
Yes, Gaurav Gupta, MD is currently recruiting for 5 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Gaurav Gupta, MD has studied deeply?
Yes, Gaurav Gupta, MD has studied treatments such as Letermovir, Prophylaxis (P2W), Transmit and Treat (T&T).
What is the best way to schedule an appointment with Gaurav Gupta, MD?
Apply for one of the trials that Gaurav Gupta, MD is conducting.
What is the office address of Gaurav Gupta, MD?
The office of Gaurav Gupta, MD is located at: Virginia Commonwealth University, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.